Aims & Scope

Genetic Engineering & Biotechnology News (GEN) is the most widely-read publication covering tools, techniques, and technologies in the biotechnology industry; a site-wide license is important for academic, corporate, and government institutions to foster global collaborations among these sectors and to keep them abreast of the urgent issues that will affect the field.

Covering bench to bedside for over 35 years, GEN's unique news and technology focus includes the entire bioproduct life cycle from early-stage R&D, to applied research including OMICS, biomarkers, as well as diagnostics, to bioprocessing and commercialization.

For Institutional Subscribers: the fully searchable Literatum platform

  • COUNTER 3 compliance
  • Unlimited, simultaneous access
  • Multiple ways of searching and crossreferencing
  • Authenticated mobile access via Liebert for Mobile (L4M)

Indexed/Abstracted in:

Science Citation Index Expanded;

Biotechnology Citation Index®;

The views, opinions, findings, conclusions and recommendations set forth in any Journal article are solely those of the authors of those articles and do not necessarily reflect the views, policy or position of the Journal, its Publisher, its editorial staff or any affiliated Societies and should not be attributed to any of them.